DRMAW vs WY
Dermata Therapeutics Inc. Warrant (DRMAW) versus Weyerhaeuser Company (WY) — a side-by-side from cached financials, not a winner call.
Dermata Therapeutics Inc. Warrant (DRMAW) common stock listed on NASDAQ.
Weyerhaeuser Company (WY) is a reit - specialty company listed on NYSE.
DRMAW does not have a complete income-statement cache yet.
Latest reported WY revenue for 2026-06-30 was $3.59B. Net income was $318.0M. WY currently screens at market cap $17.54B and trailing P/E 43.4.
DRMAW currently screens at market cap $0. WY currently screens at market cap $17.54B and trailing P/E 43.4.
Not investment advice. Open the DRMAW and WY stock pages for the full models.
Not investment advice.